UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work
UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work
Read moreUK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work
Read more(Sharecast News) - University intellectual property commercialisation company Frontier IP noted an announcement below from its portfolio company The Vaccine Group (TVG) on Friday, about the material progress it was making with its novel vaccine technology, and the start of work on a Covid-19 coronavirus vaccine for use in animals.
Read moreFrontier IP's Vaccine Group Working On Covid-19 Vaccine For Animals
Read moreFrontier IP Investee Secures EU Funding For Microscope Development
Read moreFrontier IP Ups Stake In AI Firm Celerum Amid "Industry Interest"
Read moreFrontier IP Notes First Trials Of Exscientia's OCD Drug Candidate
Read moreFrontier IP Investee Vaccine Group Secures GBP680,000 In Funding
Read more(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Tuesday that its portfolio company, Fieldwork Robotics, has raised £0.298m through an initial equity funding round.
Read moreFrontier IP Investee Fieldwork Robotics Raises Almost GBP300,000
Read more(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Friday that its portfolio company Exscientia, which focuses on artificial intelligence (AI) driven drug discovery, has entered into a collaboration with Bayer focused on cardiovascular disease and oncology.
Read moreUPDATE: Frontier IP Raises GBP3.8 Million Via Oversubscribed Placing
Read moreFrontier IP To Raise GBP3.5 Million As Annual Profit Rises Sharply
Read more(Sharecast News) - Frontier IP on Wednesday reported that its annual profits more than doubled after a rise in the fair value of its investments led to a leap in revenue.
Read moreFrontier IP Takes 43% Interest In University Plagiarism Screening Firm
Read more(Alliance News) - Investment firm Frontier IP Group PLC said Friday its portfolio artificial intelligence drug discovery company Exscientia had entered into a partnership with biotechnology firm -
Read more